Factors associated with overweight and obesity in schizophrenia, schizoaffective and bipolar disorders

Psychiatry Research

Volumn 237, Issue , 2016, Pages 304-310

  Chouinard, Virginie Anne ^a,b   Pingali, Samira M ^a   Chouinard, Guy ^c   Henderson, David C ^b,d,e   Mallya, Sonal G ^a   Cypess, Aaron M ^f   Cohen, Bruce M ^a,b   Öngür, Dost ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Affective; Bipolar; BMI; Obesity; Overweight; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; AGE; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; ETHNICITY; FAMILY HISTORY; FEMALE; GENDER; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUICIDE ATTEMPT; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; OVERWEIGHT; PSYCHOTIC DISORDERS; STATISTICS AND NUMERICAL DATA;

ADULT; BIPOLAR DISORDER; BODY MASS INDEX; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PREVALENCE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SUICIDE, ATTEMPTED;

EID: 84959153666     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2016.01.024     Document Type: Article

References (74)

1. Allison D.B., Mackell J.A., McDonnell D.D. The impact of weight gain on quality of life among persons with schizophrenia. Psychiatr. Serv. 2003, 54(4):565-567.
2. Allison D.B., Newcomer J.W., Dunn A.L., Blumenthal J.A., Fabricatore A.N., Daumit G.L., Cope M.B., Riley W.T., Vreeland B., Hibbeln J.R., Alpert J.E. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am. J. Prev. Med. 2009, 36(4):341-350.
3. Arango C., Bobes J., Kirkpatrick B., Garcia-Garcia M., Rejas J. Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the CLAMORS study. Eur. Neuropsychopharmacol. 2011, 21(12):867-875.
4. Ben-Shachar D., Laifenfeld D. Mitochondria, synaptic plasticity and schizophrenia. Int. Rev. Neurobiol. 2004, 59:273-296.
5. Bond D.J., Ha T.H., Lang D.J., Su W., Torres I.J., Honer W.G., Lam R.W., Yatham L.N. Body mass index-related regional gray and white matter volume reductions in first-episode mania patients. Biol. Psychiatry 2014, 76(2):138-145.
6. Bond D.J., Kunz M., Torres I.J., Lam R.W., Yatham L.N. The association of weight gain with mood symptoms and functional outcomes following a first manic episode: prospective 12-month data from the systematic treatment optimization program for early mania (STOP-EM). Bipolar Disord. 2010, 12(6):616-626.
7. Bond D.J., Lang D.J., Noronha M.M., Kunz M., Torres I.J., Su W., Honer W.G., Lam R.W., Yatham L.N. The association of elevated body mass index with reduced brain volumes in first-episode mania. Biol. Psychiatry 2011, 70(4):381-387.
8. Calkin C., van de Velde C., Ruzickova M., Slaney C., Garnham J., Hajek T., O'Donovan C., Alda M. Can body mass index help predict outcome in patients with bipolar disorder?. Bipolar Disord. 2009, 11(6):650-656.
9. Calkin C.V., Ruzickova M., Uher R., Hajek T., Slaney C.M., Garnham J.S., O'Donovan M.C., Alda M. Insulin resistance and outcome in bipolar disorder. Br. J. Psychiatry 2014, 206(1):52-57.
10. Centorrino F., Masters G.A., Talamo A., Baldessarini R.J., Ongur D. Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics. Hum. Psychopharmacol. 2012, 27(5):521-526.
11. Correll C.U., Robinson D.G., Schooler N.R., Brunette M.F., Mueser K.T., Rosenheck R.A., Marcy P., Addington J., Estroff S.E., Robinson J., Penn D.L., Azrin S., Goldstein A., Severe J., Heinssen R., Kane J.M. Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study. JAMA Psychiatry 2014, 71(12):1350-1363.
12. Crawford M.J., Jayakumar S., Lemmey S.J., Zalewska K., Patel M.X., Cooper S.J., Shiers D. Assessment and treatment of physical health problems among people with schizophrenia: national cross-sectional study. Br. J. Psychiatry 2014, 205(6):473-477.
13. Crump C., Winkleby M.A., Sundquist K., Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am. J. Psychiatry 2013, 170(3):324-333.
14. Cypess A.M., Kahn C.R. Brown fat as a therapy for obesity and diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17(2):143-149.
15. Daumit G.L., Anthony C.B., Ford D.E., Fahey M., Skinner E.A., Lehman A.F., Hwang W., Steinwachs D.M. Pattern of mortality in a sample of Maryland residents with severe mental illness. Psychiatry Res. 2010, 176(2-3):242-245.
16. de Wit L., Luppino F., van Straten A., Penninx B., Zitman F., Cuijpers P. Depression and obesity: a meta-analysis of community-based studies. Psychiatry Res. 2010, 178(2):230-235.
17. Dipasquale S., Pariante C.M., Dazzan P., Aguglia E., McGuire P., Mondelli V. The dietary pattern of patients with schizophrenia: a systematic review. J. Psychiatr. Res. 2013, 47(2):197-207.
18. Druss B.G., Zhao L., Von Esenwein S., Morrato E.H., Marcus S.C. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med. Care 2011, 49(6):599-604.
19. 31P magnetization transfer spectroscopy. JAMA Psychiatry 2014, 71(1):19-27.
20. Elmslie J.L., Mann J.I., Silverstone J.T., Williams S.M., Romans S.E. Determinants of overweight and obesity in patients with bipolar disorder. J. Clin. Psychiatry 2001, 62(6):486-491.
21. Fagiolini A., Frank E., Houck P.R., Mallinger A.G., Swartz H.A., Buysse D.J., Ombao H., Kupfer D.J. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J. Clin. Psychiatry 2002, 63(6):528-533.
22. Fagiolini A., Kupfer D.J., Houck P.R., Novick D.M., Frank E. Obesity as a correlate of outcome in patients with bipolar I disorder. Am. J. Psychiatry 2003, 160(1):112-117.
23. Fagiolini A., Kupfer D.J., Rucci P., Scott J.A., Novick D.M., Frank E. Suicide attempts and ideation in patients with bipolar I disorder. J. Clin. Psychiatry 2004, 65(4):509-514.
24. Field A.E., Coakley E.H., Must A., Spadano J.L., Laird N., Dietz W.H., Rimm E., Colditz G.A. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch. Intern. Med. 2001, 161(13):1581-1586.
25. CDC Division of Nutrition, Physical Activity and Obesity, 2012. Massachusetts State Nutrition, Physical Activity and Obesity Profile. Centers for Disease Control and Prevention.
26. First M.B., Sptizer R.L., Gibbons M., Williams J.B.W. Structured clinical interview for DSM-IV Axis I Disorders. Biometrics Research 1995, State Psychiatric Institute, New York: New York.
27. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303(3):235-241.
28. Fontaine K.R., Heo M., Harrigan E.P., Shear C.L., Lakshminarayanan M., Casey D.E., Allison D.B. Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate. Psychiatry Res. 2001, 101(3):277-288.
29. Goldstein B.I., Liu S.M., Zivkovic N., Schaffer A., Chien L.C., Blanco C. The burden of obesity among adults with bipolar disorder in the United States. Bipolar Disord. 2011, 13(4):387-395.
30. Hajek T., Calkin C., Blagdon R., Slaney C., Alda M. Type 2 diabetes mellitus: a potentially modifiable risk factor for neurochemical brain changes in bipolar disorders. Biol. Psychiatry 2013, 77(3):295-303.
31. Hajek T., Calkin C., Blagdon R., Slaney C., Uher R., Alda M. Insulin resistance, diabetes mellitus and brain structure in bipolar disorders. Neuropsychopharmacology 2014, 39(12):2910-2918.
32. Haslam D.W., James W.P. Obesity. Lancet 2005, 366(9492):1197-1209.
33. Henderson D.C. Weight gain with atypical antipsychotics: evidence and insights. J. Clin. Psychiatry Suppl. 2007, 12:18-26.
34. International Schizophrenia Consortium, Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460(7256):748-752.
35. Ivleva E.I., Morris D.W., Moates A.F., Suppes T., Thaker G.K., Tamminga C.A. Genetics and intermediate phenotypes of the schizophrenia--bipolar disorder boundary. Neurosci. Biobehav. Rev. 2010, 34(6):897-921.
36. Kolotkin R.L., Corey-Lisle P.K., Crosby R.D., Swanson J.M., Tuomari A.V., L'Italien G., Mitchell, J.E.J. Impact of obesity on health-related quality of life in schizophrenia and bipolar disorder. Obesity 2008, 16(4):749-754.
37. Laursen T.M., Munk-Olsen T., Vestergaard M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr. Opin. Psychiatry 2012, 25(2):83-88.
38. Leucht S., Tardy M., Komossa K., Heres S., Kissling W., Davis J.M. Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database Syst. Rev. 2012, 16(5).
39. Luppino F.S., de Wit L.M., Bouvy P.F., Stijnen T., Cuijpers P., Penninx B.W., Zitman F.G. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch. Gen. Psychiatry 2010, 67(3):220-229.
40. Maina G., Salvi V., Vitalucci A., D'Ambrosio V., Bogetto F. Prevalence and correlates of overweight in drug-naive patients with bipolar disorder. J. Affect. Disord. 2008, 110(1-2):149-155.
41. Manu P., Khan S., Radhakrishnan R., Russ M.J., Kane J.M., Correll C.U. Body mass index identified as an independent predictor of psychiatric readmission. J. Clin. Psychiatry 2014, 75(6):e573-e577.
42. Marchbanks R.M., Mulcrone J., Whatley S.A. Aspects of oxidative metabolism in schizophrenia. Br. J. Psychiatry 1995, 167(3):293-298.
43. Mather A.A., Cox B.J., Enns M.W., Sareen J. Associations of obesity with psychiatric disorders and suicidal behaviors in a nationally representative sample. J. Psychosom. Res. 2009, 66(4):277-285.
44. McElroy S.L., Frye M.A., Suppes T., Dhavale D., Keck P.E., Leverich G.S., Altshuler L., Denicoff K.D., Nolen W.A., Kupka R., Grunze H., Walden J., Post R.M. Correlates of overweight and obesity in 644 patients with bipolar disorder. J. Clin. Psychiatry 2002, 63(3):207-213.
45. McIntyre R.S., McElroy S.L., Konarski J.Z., Soczynska J.K., Bottas A., Castel S., Wilkins K., Kennedy S.H. Substance use disorders and overweight/obesity in bipolar I disorder: preliminary evidence for competing addictions. J. Clin. Psychiatry 2007, 68(9):1352-1357.
46. Meyer J.M., Nasrallah H.A., McEvoy J.P., Goff D.C., Davis S.M., Chakos M., Patel J.K., Keefe R.S., Stroup T.S., Lieberman J.A. The clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial: clinical comparison of subgroups with and without the metabolic syndrome. Schizophr. Res. 2005, 80(1):9-18.
47. Mitchell A.J., Lord O. Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis. J. Psychopharmacol. 2010, 24(4 Suppl):69-80.
48. Nieto-Garcia F.J., Bush T.L., Keyl P.M. Body mass definitions of obesity: sensitivity and specificity using self-reported weight and height. Epidemiology 1990, 1(2):146-152.
49. Nordentoft M., Wahlbeck K., Hallgren J., Westman J., Osby U., Alinaghizadeh H., Gissler M., Laursen T.M. Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. Plos One 2013, 8(1):e55176.
50. Nyholm M., Gullberg B., Merlo J., Lundqvist-Persson C., Råstam L., Lindblad U. The validity of obesity based on self-reported weight and height: implications for population studies. Obes. (Silver Spring) 2007, 15(1):197-208.
51. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9(1):97-113.
52. Ongur D., Prescot A.P., Jensen J.E., Cohen B.M., Renshaw P.F. Creatine abnormalities in schizophrenia and bipolar disorder. Psychiatry Res. 2009, 172(1):44-48.
53. Palmese L.B., DeGeorge P.C., Ratliff J.C., Srihari V.H., Wexler B.E., Krystal A.D., Tek C. Insomnia is frequent in schizophrenia and associated with night eating and obesity. Schizophr. Res. 2011, 133(1-3):238-243.
54. Pettegrew J.W., Keshavan M.S., Panchalingam K., Strychor S., Kaplan D.B., Tretta M.G., Allen M. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch. Gen. Psychiatry 1991, 48(6):563-568.
55. Ratliff J.C., Palmese L.B., Reutenauer E.L., Srihari V.H., Tek C. Obese schizophrenia spectrum patients have significantly higher 10-year general cardiovascular risk and vascular ages than obese individuals without severe mental illness. Psychosomatics 2013, 54(1):67-73.
56. Rimm E.B., Stampfer M.J., Colditz G.A., Chute C.G., Litin L.B., Willett W.C. Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1990, 1(6):466-473.
57. Rummel-Kluge C., Komossa K., Schwarz S., Hunger H., Schmid F., Lobos C.A., Kissling W., Davis J.M., Leucht S. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr. Res. 2010, 123(2-3):225-233.
58. Sicras-Mainar A., Maurino J., Ruiz-Beato E., Navarro-Artieda R. Impact of negative symptoms on healthcare resource utilization and associated costs in adult outpatients with schizophrenia: a population-based study. BMC Psychiatry 2014, 14(1):225.
59. Spelman L.M., Walsh P.I., Sharifi N., Collins P., Thakore J.H. Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia. Diabeties Med. 2007, 24(5):481-485.
60. Spencer E.A., Appleby P.N., Davey G.K., Key T. Validity of self-reported height and weight. Public Health Nutr. 2002, 5(4):561-565.
61. Srihari V.H., Phutane V.H., Ozkan B., Chwastiak L., Ratliff J.C., Woods S.W., Tek C. Cardiovascular mortality in schizophrenia: defining a critical period for prevention. Schizophr. Res. 2013, 146(1-3):64-68.
62. Strassnig M., Brar J.S., Ganguli R. Body mass index and quality of life in community-dwelling patients with schizophrenia. Schizophr. Res. 2003, 62(1-2):73-76.
63. Strauss R.S. Self-reported weight status and dieting in a cross-sectional sample of young adolescents: National Health and Nutrition Examination Survey III. Arch. Pediatr. Adolesc. Med. 1999, 153(7):741-747.
64. Sugiyama T., Tsugawa Y., Tseng C.H., Kobayashi Y., Shapiro M.F. Different time trends of caloric and fat intake between statin users and nonusers among US adults: gluttony in the time of statins? JAMA. Intern Med. 2014, 174(7):1038-1045.
65. Susce M.T., Villanueva N., Diaz F.J., de Leon J. Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey. J. Clin. Psychiatry 2005, 66(2):167-173.
66. Suvisaari J.M., Saarni S.I., Perala J., Suvisaari J.V., Harkanen T., Lonnqvist J., Reunanen A. Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. J. Clin. Psychiatry 2007, 68(7):1045-1055.
67. Thakore J.H., Mann J.N., Vlahos I., Martin A., Reznek R. Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int. J. Obes. Relat. Metab. Disord. 2002, 26(1):137-141.
68. Troiano R.P., Frongillo E.A.Jr, Sobal J., Levitsky D.A. The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. Int. J. Obes. Relat. Metab. Disord. 1996, 20(1):63-75.
69. Tsai K.Y., Lee C.C., Chou Y.M., Su C.Y., Chou F.H. The incidence and relative risk of stroke in patients with schizophrenia: a five-year follow-up study. Schizophr. Res. 2012, 138(1):41-47.
70. Vancampfort D., Probst M., Knapen J., Carraro A., De Hert M. Associations between sedentary behaviour and metabolic parameters in patients with schizophrenia. Psychiatry Res. 2012, 200(2-3):73-78.
71. van Welie H., Derks E.M., Verweij K.H., de Valk H.W., Kahn R.S., Cahn W. The prevalence of diabetes mellitus is increased in relatives of patients with a non-affective psychotic disorder. Schizophr. Res. 2013, 143(2-3):354-357.
72. van Winkel R., van Os J., Celic I., Van Eyck D., Wampers M., Scheen A., Peuskens J., De Hert M. Psychiatric diagnosis as an independent risk factor for metabolic disturbances: results from a comprehensive, naturalistic screening program. J. Clin. Psychiatry 2008, 69(8):1319-1327.
73. Wang P.W., Sachs G.S., Zarate C.A., Marangell L.B., Calabrese J.R., Goldberg J.F., Sagduyu K., Miyahara S., Ketter T.A. Overweight and obesity in bipolar disorders. J. Psychiatr. Res. 2006, 40(8):762-764.
74. WHO Expert Committee on Physical Status, 1995. Physical Status: The Use and Interpretation of Anthropometry. World Health Organization, Geneva, Switzerland.